Skip to main content
Full access
Perspectives
Published Online: 1 February 2015

Piecing Together Mother’s Stress and Baby’s Genetics to Understand Brain Development

Human pregnancy is a unique biological and psychological enterprise. It can be argued that no other human life event is more important for the baby, nor more anxiety-provoking for the mother, than pregnancy. In large surveys of stressful life events, it is in the top group, just below marriage (1). The circumstances of pregnancy vary. Conception itself can be planned, a surprise, or, in instances of violence, forced upon a woman, and the healthy outcome of the pregnancy for both mother and child is inevitably a focus of concern. Most pregnant women experience quantitative elevations of anxiety during pregnancy. But how much worry is too much? How a woman and her unborn child experience the anxiety of pregnancy is the result of a complex interplay between the woman’s environment and biology (genome, epigenome, and brain functioning) and that of the fetus. Thousands of scientific reports have provided evidence of the negative sequelae associated with antenatal anxiety, along with depression, substance abuse, pregnancy-emergent health problems, adversity, and socioeconomic disadvantage (2). Yet few of these studies have provided clear scientific evidence on causal links between a stressor and the development of the child in utero.
The article by Anqi Qiu, Ph.D., et al. (3), in this issue of the Journal, provides one important example of how to advance the study of the effects of the mother’s state during pregnancy on the child’s development. By combining state-of-the-art phenotypic, genomic, neuroimaging, and statistical methods, Qiu et al. advance the investigation of the etiopathologic relations between maternal anxiety and child outcomes. Understanding how maternal anxiety interacts with offspring genomic architecture and ultimately leads to changes in the structure of the neonatal brain may provide clues as to why some children struggle from birth and others do not. Qiu et al. studied the effect of maternal anxiety on neonatal brain structure through the use of novel methods and design (GUSTO [Growing Up in Singapore Toward Health Outcomes]). They obtained T2-weighted MRI scans of 189 neonates at 5 to 17 days of life and measured the thickness of the neocortex in several regions. This thickness at birth indicates the degree of development of the neurons and connections in the child’s brain during fetal development.
The investigators assessed maternal anxiety at the mid-third trimester of pregnancy to generate a single score combining anxiety levels both at that time and before pregnancy. These anxiety measures were correlated with the mother’s household income and her ethnicity, which could be Chinese, Malay, or Indian in Singapore where the study was conducted. Catechol-O-methyltransferase (COMT) genetic differences were captured by polymorphisms at three genetic locations, the best known of which is the val-met amino acid coding difference. Some differences in genotype between the three ethnic types exist, and these differences, inevitable in any human genetic study, were controlled for. Final analyses took birth weight and length of gestation into account. The results showed that neither the mother’s anxiety nor the baby’s genotype by themselves affected the thickness of the baby’s cortex. However, in several regions, there were different effects of maternal stress, depending on the baby’s genotype. For example, in the right ventromedial prefrontal cortex, an area involved with the regulation of anxiety and mood, maternal anxiety decreased cortical thickness in babies with two copies of the COMT met allele but increased cortical thickness in babies with two copies of the more common COMT val allele. The investigators point out that dissecting this complex interaction helps pinpoint effects of the mother’s anxiety on the baby’s brain development that would be obscured in most studies that did not consider the baby’s own genetic predisposition.
The GUSTO design is unique in that it removes the biggest scientific obstacle that faces most birth cohort studies that aim to examine antenatal factors. In the majority of birth cohort imaging studies that study the offspring years after birth, perhaps even into adulthood, the participant continues to reside with his or her mother and thus is continuously exposed to the mother’s environment and, with respect to this research question, her anxiety. It is then not possible to tease out whether the effects of maternal anxiety on the child are a result of antenatal or postnatal effects. The elegance of the design in the GUSTO study is that it allows us to know the burden of antenatal maternal anxiety on the baby’s brain shortly after birth. In addition, as the GUSTO sample ages, the investigative team will be able to test for effects of postnatal maternal factors as well.
Given the wide array of genomic strategies Qiu et al. had at their disposal, the choice of possible genetic variables can be less than straightforward. However, they make a logical decision that is informed by the literature. By anchoring their choice to a candidate gene for which extensive basic science and genetic neuroimaging evidence exists, the authors provide us with a biologically plausible explanation of how the environment might interact with the genome to influence the proteome (e.g., cortical thickness). COMT, perhaps the second most studied gene in human behavior research (relative to the serotonin transporter [SERT] gene), is an appropriate choice. Qiu et al. draw from key basic neuroscience references, providing evidence for COMT playing a significant role in catecholamine signaling in the prefrontal cortex (46). In addition, multiple studies are presented that demonstrate the contribution of COMT variation in the cortical thickness of the prefrontal, temporal, and parietal regions in neonates and adolescents (7, 8). Lastly, the authors provide the arguments that the same COMT variants play a key role in a variety of emotional behavioral phenotypes, including anxiety (9).
From this study, we learn that maternal anxiety during pregnancy may have effects on offspring brain structure and quite possibly longer-term effects on the child’s arc of emotional and intellectual development. Even at this stage, the baby’s own genetic status can either amplify or prevent such effects. Developing an evidence base that demonstrates the biological links between environmental factors, genetic risk, and brain structure and function may help set future research and intervention agendas. Given how common antenatal anxiety is, and how responsive anxiety is to social supports and meditation (10), exercise (11), and cognitive-behavioral therapy (12), it seems obvious that a new type of birth cohort study should follow. It is tantalizing to envision a study in which the power of genomics and neuroimaging is applied to the effects of an interventional birth cohort design aimed at treating maternal anxiety and estimating the effects on newborns’ cortical thickness.
It would be wonderful to see whether the brains of babies born to anxious mothers who benefit from health promotion and prevention will be free of the scars of antenatal anxiety, regardless of their genotypes.

Footnote

Dr. Hudziak has received research grant support from NIMH and the National Institute of Child Health and Human Development. Dr. Freedman has reviewed this editorial and found no evidence of influence from these relationships.

References

1.
Holmes TH, Rahe RH. The Social Readjustment Rating Scale. J Psychosom Res 1967; 11:213–218
2.
Hudziak JJ, Novins DK: Illuminating the complexities of developmental psychopathology: special series on longitudinal and birth cohort studies. J Am Acad Child Adolesc Psychiatry 2013; 52:6–8
3.
Qiu A, Tuan TA, Ong ML, et al: COMT haplotypes modulate associations of antenatal maternal anxiety and neonatal cortical morphology. Am J Psychiatry 2015; 172:163–172
4.
Kang HJ, Kawasawa YI, Cheng F, et al: Spatio-temporal transcriptome of the human brain. Nature 2011; 478:483–489
5.
Tunbridge EM, Weickert CS, Kleinman JE, et al: Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cerebral Cortex 2007; 17:1206–1212
6.
Mier D, Kirsch P, Meyer-Linderberg A: Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Mol Psychiatry 2014; 15:918–927
7.
Knickmeyer RC, Wang J, Zhu H, et al: Common variants in psychiatric risk genes predict brain structure at birth. Cerebral Cortex 2014; 24:1230–1246
8.
Raznahan A, Greenstein D, Lee Y, et al: Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls. Neuroimage 2011; 57:1517–1523
9.
Desbonnet L, Tighe O, Karayiorgou M, et al: Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficient mice. Behav Brain Res 2012; 228:351–358
10.
Woolhouse H, Mercuri K, Judd F, et al: Antenatal mindfulness intervention to reduce depression, anxiety and stress: a pilot randomised controlled trial of the MindBabyBody program in an Australian tertiary maternity hospital. BMC Pregnancy Childbirth 2014; 14:369
11.
Uysal N, Sisman AR, Dayi A, et al: Maternal exercise decreases maternal deprivation induced anxiety of pups and correlates to increased prefrontal cortex BDNF and VEGF. Neuroscience Letters 2011; 505:273–278
12.
Ladouceur R, Dugas MJ, Freeston MH, et al: Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder: evaluation in a controlled clinical trial. J Consult Clin Psychol 2000; 68:957–964

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 111 - 112
PubMed: 25640928

History

Accepted: November 2014
Published online: 1 February 2015
Published in print: February 01, 2015

Authors

Details

Jim Hudziak, M.D.
From the Department of Psychiatry, University of Vermont, Burlington, Vt.

Notes

Address correspondence to Dr. Hudziak ([email protected]).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share